Company / Profit Margin
Catalyst Pharmaceuticals Partners, Inc. Profit Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
36.4%
FY2025
5-year range
17.9% / 38.8%
FY2021-FY2025
Trend
+9.2%
vs FY2024
Sector context
#13 of 146
Health Care
What the data says
Among 146 Health Care companies, Catalyst Pharmaceuticals Partners, Inc. is in the top 9% for profit margin. Profit Margin has fluctuated over the past 8 years, ranging from -6800.7% in FY2018 to 63.0% in FY2020.
Based on SEC 10-K filings.
36.4% in FY2025 with a 5-year CAGR of -26.6%. Top quartile in the Health Care sector.
Improved from 17.9% to 36.4% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -2.4pp
- 5-Year Change
- -26.6pp
- 10-Year Change
- -
Sector benchmark
Top 9% in Health CareTop 9% of 146This company 36.4% Sector average -796.3%
▼
+104.6% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 9.2% year-over-year.
- Currently 832.7pp above the Health Care sector average.
- Peak profit margin was recorded in FY2020.
- Lowest profit margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 36.4% | +9.2% |
| FY2024 | 33.3% | +85.9% |
| FY2023 | 17.9% | -53.8% |
| FY2022 | 38.8% | +38.4% |
| FY2021 | 28.0% | -55.5% |
| FY2020 | 63.0% | +102.1% |
| FY2019 | 31.2% | +100.5% |
| FY2018 | -6800.7% | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026